Biofrontera (BFRIW) Accumulated Expenses (2021 - 2025)

Biofrontera's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 15.53% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 15.53% YoY), while the FY2025 annual figure was $2.8 million, up 15.53% from the prior year.
• Accumulated Expenses was $2.8 million for Q4 2025 at Biofrontera, down from $3.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $5.6 million in Q4 2021 to a low of $2.4 million in Q2 2025.
• Historically, Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $2.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses sank 55.36% in 2022, then increased 15.53% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $5.6 million in 2021, then tumbled by 55.36% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then fell by 2.88% to $2.4 million in 2024, then grew by 15.53% to $2.8 million in 2025.
• The last three Accumulated Expenses figures came in at $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.